Few eligible patients receive prescriptions for weight-loss medications.
Liver injury episodes due to kratom (Mitragyna speciosa) are increasing in the United States, and chemical analysis can confirm the presence of this botanical in herbal and dietary supplements linked to cases of severe liver injury.
Patients with recurrent Clostridioides difficile infection (CDI) who receive treatment with fecal microbiota transplantation (FMT) are less likely to develop a primary bloodstream infection (BSI) than those receiving antibiotics.
For older patients with type 2 diabetes mellitus, higher levels of seroprotection against the hepatitis B virus were obtained following the receipt of the 2-dose vaccine vs the 3-dose vaccine.
For patients with obesity undergoing bariatric surgery, losing at least 20 to 35 percent of total body weight is associated with a more than 50 percent reduction in the risk for cancer.
Seriously ill Medicare enrollees experience considerable financial distress.
The FDA has approved Talicia (omeprazole magnesium, amoxicillin and rifabutin delayed-release capsules; RedHill Biopharma) for the treatment of Helicobacter pylori (H. pylori) infection in adults.
The FDA has released a summary of the results from tests evaluating ranitidine products for the probable carcinogen N-Nitrosodimethylamine.
Only half of oncologists who discuss genomic testing with patients report that they often discuss the likely costs of testing and related treatments.